Gary Nabel (Sanofi)
Two top execs in Sanofi's R&D group are hitting the exit in a shakeup as Frank Nestle moves up to CSO
Roger Perlmutter isn’t the only Big Pharma R&D exit being announced today.
Sanofi says that Gary Nabel, named chief scientific officer 8 years ago …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
